- You should not expect any direct benefits from taking part.
- Your help and the information we obtain from this study may improve our understanding of the heart’s structure and function in HCM and the possible risk of developing complications in the future. If successful, this will help guide doctors to find a better treatment for this condition.
- We may reimburse reasonable travel and parking expenses to and from the hospital (specific details for each site involved in this study are provided in the participant information leaflet).
- You will not receive any payments for participating in this study.
People enrolled
2750
The HCMR study is well under way, with the first participant enrolled in April 2014 at research site 001. There are now 44 active sites; 22 sites in North America and 22 sites in Europe. The study is now following up the 2750 patients that were enrolled and is no longer recruiting.
Translate
The Health Research Authority’s National Research Ethics Service Committee – South Central Oxford A, has reviewed and approved this research study and website
HRA NRES Research Ethics Reference Number 14/SC/0190